Featured Post

Beyond SSRIs: Why the Next Advance in GAD May Not Target Monoamines

July 7, 2026

DT120 (lysergide), a 5-HT2A agonist, eased GAD anxiety in trial. Beyond SSRIs/SNRIs, psychoplastogens offer new remission path.
 Read More

Other top stories

Generalized Anxiety Disorder: A Persistent Burden and a New Look at Psychedelics

July 7, 2026

Why Your Psychiatric Patients Aren’t Sleeping: CBT-I and a Pathway That Finally Works

March 30, 2026

The Sleep Disorder You Are Missing in Your Psychiatric Patients & The Modern Solution For It

March 11, 2026

The latest news on Depression (MDD)

Other stories

Brain Training Could Delay Dementia for Years

February 11, 2026

Psychosis Soars in Younger Generations

February 10, 2026

Ketogenic Diet Shows Modest Mental Health Benefits

February 9, 2026

Group Exercise Delivers Mental Health Gains

February 6, 2026

Weekly Mind Reader: Daylight Doesn’t Matter

February 6, 2026

Grandparenting May Sharpen the Mind

February 5, 2026

Live Webinar
and Q&A With
Dr Deligiannidis

JULY 16 · REGISTER NOW
Webinar ad featuring Dr. Kristina M. Deligiannidis on PPD treatment options

Subscribe to read
more articles

Subscribe